✦ LIBER ✦

PDB7 COST IMPACT ASSOCIATED WITH INTRODUCTION OF THIAZOLIDINEDIONE THERAPY IN MEDICAID ENROLLED TYPE 2 DIABETES PATIENTS

✍ Scribed by R Balkrishnan; R Shenolikar; R Rajagopalan; F Camacho; RT Anderson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB30 COSTS AND ADHERENCE ASSOCIATED WIT

✍ R Balkrishnan; R Shenolikar; R Rajagopalan; F Camacho; RT Anderson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PDB63 EFFECTS OF DOSING REGIMEN ON RESOU

✍ SS Jayawant; B Arondekar; E Seiber; V Lacombe; R Balkrishnan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Health Care Costs and Medication Adheren

✍ Manjiri D. Pawaskar; Fabian T. Camacho; Roger T. Anderson; David Cobden; Ashish 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 938 KB

Comparisons of Rosiglitazone Versus Piog

✍ Rajesh Balkrishnan; Bhakti V. Arondekar; Fabian T. Camacho; Rahul A. Shenolikar; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 787 KB

PDB14 ECONOMIC OUTCOMES ASSOCIATED WITH

✍ MD Pawaskar; F Camacho; RT Anderson; D Cobden; AV Joshi; R Balkrishnan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

DB3 OUTCOMES ASSOCIATED WITH THE INTRODU

✍ R Balkrishnan; R Rajagopalan; F Camacho; R Anderson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB